Back to Search
Start Over
Serum glutathione peroxidase 3 as a biomarker of postoperative relapse in patients with lung cancer∗
- Source :
- Journal of Thoracic Oncology. (2):S35
- Publisher :
- Published by Elsevier Inc.
-
Abstract
- Background: Glutathione peroxidase 3 (GPx3) which is an extracellular secretory protein is down regulated in patients with early stage lung cancer. We examined the usefulness of serum GPx3 as a biomarker for monitoring of relapse after surgery. Methods: We prospectively collected serial serum samples at baseline, 3 months (3m), 6 months (6m), and 12 months (12m) after operation from the patients who underwent surgery during the year 2013. GPx3 levels were measured three times per sample using the enzyme-linked immunosorbent assay, and the mean values were analyzed by t-test and paired t-test. Results: A total of 170 (100 adenocarcinoma, 41 squamous cell carcinoma, 29 others) patients were analyzed in this study. Mean age was 64.1 years old (range, 39-80) and 27 (15.9%) out of 165 lung cancer patients were confirmed relapse during the median follow-up period of 597.5 days (range, 5-938). The mean GPx3 value at postoperative 6m was significantly elevated in relapsed group than control group (7.90 ± 2.44 mg/mL vs. 6.99 ± 1.79 mg/mL, p1⁄40.047). The mean GPx3 differences were significantly higher in relapsed group than control group at 3m (-0.38 ± 0.39 mg/mL vs. -0.21 ± 0.36 mg/mL, p1⁄40.044), 6m (-0.37 ± 0.42 mg/mL vs. -0.19 ± 0.30 mg/mL, p1⁄40.024), and 12m (-0.38 ± 0.42 mg/mL vs. -0.19 ± 0.28 mg/mL, p1⁄40.012). The mean time to relapse was significantly shorter in high level of GPx3 group at postoperative 3m (694.83 ± 31.86 days vs. 839.05 ± 24.31 days, p1⁄40.007). The mean time to relapse was significantly shorter in high GPx3 difference group between baseline and postoperative 3m (729.76 ± 34.89 days vs. 838.18 ± 24.03 days, p1⁄40.002). Conclusion: Serum mean GPx3 value at postoperative 6m and the mean GPx3 difference were significantly elevated in relapsed lung cancer. The mean time to relapse was significantly shorter in high level of GPx3 group at postoperative 3m. More large scaled validation studies are warranted.
- Subjects :
- Pulmonary and Respiratory Medicine
0303 health sciences
medicine.medical_specialty
GPX3
business.industry
Time to relapse
medicine.disease
Serum samples
Gastroenterology
3. Good health
Surgery
03 medical and health sciences
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Internal medicine
medicine
Biomarker (medicine)
Adenocarcinoma
In patient
Basal cell
business
Lung cancer
030304 developmental biology
Subjects
Details
- Language :
- English
- ISSN :
- 15560864
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of Thoracic Oncology
- Accession number :
- edsair.doi.dedup.....f320d04155eef55529a8e30a1f66d99f
- Full Text :
- https://doi.org/10.1016/j.jtho.2015.12.059